126 reports of this reaction
2.6% of all PRUCALOPRIDE reports
#7 most reported adverse reaction
CONSTIPATION is the #7 most commonly reported adverse reaction for PRUCALOPRIDE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 126 FDA adverse event reports linking PRUCALOPRIDE to CONSTIPATION. This represents approximately 2.6% of all 4,835 adverse event reports for this drug.
Patients taking PRUCALOPRIDE who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONSTIPATION is a less commonly reported adverse event for PRUCALOPRIDE, but still significant enough to appear in the safety profile.
In addition to constipation, the following adverse reactions have been reported for PRUCALOPRIDE:
The following drugs have also been linked to constipation in FDA adverse event reports:
CONSTIPATION has been reported as an adverse event in 126 FDA reports for PRUCALOPRIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONSTIPATION accounts for approximately 2.6% of all adverse event reports for PRUCALOPRIDE, making it a notable side effect.
If you experience constipation while taking PRUCALOPRIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.